Cited by 336Endometriosis Research and TreatmentEctopic Pregnancy Diagnosis and ManagementReproductive System and Pregnancy

Progesterone resistance in endometriosis: origins, consequences and interventions

Patel, Bansari G., Rudnicki, Martin, Yu, Jie, Shu, Yimin, Taylor, Robert N.·2017·Acta Obstetricia Et Gynecologica Scandinavica

Abstract

Endometriosis is a common cause of pelvic pain and affects up to 10% of women of reproductive age. Aberrant progesterone signaling in the endometrium plays a significant role in impaired decidualization and establishment of ectopic endometrial implants. Eutopic endometrial cells from women with endometriosis fail to downregulate genes needed for decidualization, such as those involved in cell cycle regulation, leading to unbridled proliferation. Several causes of progesterone resistance in the endometrium have been postulated, including congenital "preconditioning", whereby the in utero environment renders infants susceptible to neonatal uterine bleeding and endometriosis. Progesterone action is crucial to decreasing inflammation in the endometrium, and deviant progesterone signaling results in a proinflammatory phenotype. Conversely, chronic inflammation can induce a progesterone-resistant state. Repetitive retrograde endometrial shedding begets chronic peritoneal inflammation, which further exacerbates progesterone resistance. Genetic causes of progesterone resistance include progesterone receptor gene polymorphisms, altered microRNA expression, and epigenetic modifications to progesterone receptors and their targets. Environmental toxins such as dioxin play a possible role in the genesis of endometriosis by permitting an inflammatory milieu. A consequence of impaired progesterone action is that hormonal therapy is rendered ineffective for a subset of women with endometriosis. Synthetic progestins, such as dienogest, may overcome this phenomenon by increasing progesterone receptor expression and decreasing proinflammatory cytokines. Other modalities include high dose depot formulations of progestins, medicated intrauterine devices and the likely advent of oral GnRH antagonists. Unearthing root causes of progesterone inaction in endometriosis will aid in the development of novel therapeutics geared toward prevention and treatment.

Integrity signals

Registry

Crossref · 10.1111/aogs.13156

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Patel, B. G., Rudnicki, M., Yu, J., Shu, Y., & Taylor, R. N.
Affiliations
  • Wake Forest University Health Sciences (US)
  • Odense University Hospital (DK)
Corresponding author
Rudnicki, Martin
Venue
Acta Obstetricia Et Gynecologica Scandinavica
Publisher
Wiley
Published
2017-05-28
Volume
96
Issue
6
Pages
623-632
ISSN
  • 0001-6349 (ISSN-L)
  • 1600-0412
OpenAlex
W2605912824
Cited by
336
References
66
Citations by year
2026: 38 · 2025: 25 · 2024: 34 · 2023: 59 · 2022: 51 · 2021: 43 · 2020: 38 · 2019: 20 · 2018: 20 · 2017: 8
FWCI
3.84
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Obstetricia Et Gynecologica Scandinavica (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
endometriosis, progesterone resistance, progesterone signaling, decidualization, endometritis, microRNA, epigenetic modifications, dioxins, progestins, dienogest, GnRH antagonist, endocrine therapy resistance, peritonitis
MeSH terms
Endometriosis, Endometrium, Environmental Pollution, Female, Humans, Progesterone, Receptors, Progesterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review